Browsing: effects
The approval of the Food and Drug Administration in 2023 of Lecanemab – a new therapy from Alzheimer’s that was…
Alzheimer’s disease, the most common cause of dementia, is currently incurable. The current available medicines have very limited efficacy and…
Scientists from Pennington Biomedical Research Center have been given more clarity in the brain areas and neurons that control metabolism,…
In the past two years, the Food and Drug Administration has approved two new Alzheimer’s therapies, based on data from…
Overcoming past challenges may require integrating traditional population science tools with innovative biomarker measures in a precision medicine framework. Study:…
According to a study published on November 21, short-term menopausal hormone therapy (MHT) had no long-term cognitive effects when given…
Researchers at Washington University School of Medicine in St. Louis have developed a way to capture the effects of aging…